Stimunity is a preclinical-stage startup company which develops best-in-class drugs on the STING pathway to activate the innate immune system. Our drugs stimulate patients' immune system to fight back infectious pathogens or cancer. Our technology is based on high level academic research work from prestigious institutions: Institut Curie, the French National Institute of Health and Medical Research (Inserm) and University of Oxford.